SCHEMBL301282

SCHEMBL301282

CN(N=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
ALOX15 P16050 2/20 0.56
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
MAPK1 P28482 5/20 0.48
TDP1 Q9NUW8 4/20 0.48
HSD17B10 Q99714 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HPGD P15428 2/20 0.48
POLB P06746 2/20 0.48
KDM4E B2RXH2 1/20 0.48
RGS12 O14924 1/20 0.48
USP2 O75604 1/20 0.48
THRB P10828 1/20 0.48
PKM P14618 1/20 0.48
NFKB1 P19838 1/20 0.48
APEX1 P27695 1/20 0.48
BRCA1 P38398 1/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10793484 0.86 ALDH1A1 (0.47) ALDH1A1ALOX15MEN1KMT2AMAPK1
SCHEMBL3123070 0.86 ALDH1A1 (0.60) ALDH1A1ALOX15MEN1KMT2AMAPK1
SCHEMBL3345549 0.83 MAPK1 (0.64) ALDH1A1ALOX15MEN1KMT2AMAPK1
SCHEMBL3345552 0.83 MAPK1 (0.64) ALDH1A1ALOX15MEN1KMT2AMAPK1
Simtrazene SCHEMBL4971 0.78 MEN1 (0.48) ALDH1A1ALOX15MEN1KMT2AMAPK1
Simtrazene SCHEMBL6312204 0.78 MEN1 (0.48) ALDH1A1ALOX15MEN1KMT2AMAPK1
SCHEMBL11550227 0.77 ALDH1A1 (0.63) ALDH1A1ALOX15MEN1KMT2AMAPK1
SCHEMBL1116059 0.77 ALDH1A1 (0.52) ALDH1A1ALOX15MEN1KMT2AMAPK1
SCHEMBL4146720 0.76 ALDH1A1 (0.48) ALDH1A1ALOX15MEN1KMT2AMAPK1
SCHEMBL9018948 0.75 ALDH1A1 (0.52) ALDH1A1ALOX15MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304541-A1 METHYLENE BLUE HAVING A REDUCED CONTENT OF N-NITROSO-AZURE B IMPURITY AND PROCESS FOR OBTAINING THE SAME Icrom S.R.L. (IT) 2025-10-02 US claimed
CN-119246753-A Universal analysis and detection method for 7 nitrosamines in medicine 上海合全药物研发有限公司 2025-01-03 CN claimed
CN-119224148-A Detection method for determining nitrosamine compounds in cold medicine based on gas chromatography-tandem mass spectrometry 绍兴市疾病预防控制中心 2024-12-31 CN claimed
CN-115504933-B Preparation method and application of polysubstituted quinolinone compound 深圳万知达企业管理有限公司 2024-12-13 CN claimed
CN-118225919-B Method for measuring nitrosamine compounds by QuEChERS-LC-MS/MS 浙江宏正检测有限公司 2024-11-26 CN claimed
CN-118878911-A Polyethylene toughened m-EPS material and preparation method thereof 沧州康美特科技有限公司 2024-11-01 CN claimed
CN-118878912-A M-EPS particles and preparation method thereof 沧州康美特科技有限公司 2024-11-01 CN claimed
CN-118225919-A Method for measuring nitrosamine compounds by QuEChERS-LC-MS/MS 浙江宏正检测有限公司 2024-06-21 CN claimed
CN-113241131-B Nitrosamine TD based on fluorescent yeast sensor 50 Prediction method 中国药科大学 2024-03-29 CN claimed
CN-114752955-B Method for electrochemically synthesizing N-nitroso-2-aminobenzophenone compound 广西师范大学 2023-06-16 CN claimed
US-20170009089-A1 ACTIVE ENERGY RAY-CURABLE INKJET INK COMPOSITION AND PRINTED PRODUCT DNP FINE CHEMICALS CO LTD (JP) 2017-01-12 US claimed
EP-1468981-B1 Production method of adamantyl acrylate compounds MITSUBISHI GAS CHEMICAL CO (JP) 2012-08-01 EP claimed
US-7067692-B2 Production method of adamantyl acrylate compounds MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2006-06-27 US claimed
US-20040210082-A1 Production method of adamantyl acrylate compounds MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2004-10-21 US claimed
EP-1468981-A1 Production method of adamantyl acrylate compounds MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2004-10-20 EP claimed
US-4535154-A ONE-STEP USING POTASSIUM HYDROXIDE AND A NICKEL-ALUMINUM CATALYST UNITED STATES OF AMERICA (US) 1985-08-13 US claimed
US-4197226-A Water-soluble coating composition NIPPON OIL CO., LTD. (JP) 1980-04-08 US claimed
US-4171308-A ADDUCT OF A BUTADIENE POLYMER AND AN A,B-UNSATURATED CARBOXY ACID COMPOUND, NEUTRALIZED NIPPON OIL CO. LTD. (JP) 1979-10-16 US claimed
US-4050993-A Distillation of readily polymerizable ethylenically unsaturated compounds COSDEN OIL & CHEMICAL COMPANY (US) 1977-09-27 US claimed
US-3952023-A Method for preparing adduct of butadiene polymer or copolymer and α, β-ethylenically unsaturated dicarboxylic acid compound NIPPON OIL COMPANY LTD. (JA) 1976-04-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040210082-A1 Production method of adamantyl acrylate compounds APEH, CYP51A1, NAAA ALDH1A1 71/4885ALOX15 280/4885MEN1 1073/4885
US-20250304541-A1 METHYLENE BLUE HAVING A REDUCED CONTENT OF N-NITROSO-AZURE B IMPURITY AND PROCESS FOR OBTAINING THE SAME MMAB, HBB, MB ALDH1A1 702/4885ALOX15 462/4885MEN1 678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.